;

REPCL potential cure for baldness utilizing Cell Replication…Review in April

RepliCel Provides Quarterly Update on First-in-man Clinical Trials VANCOUVER, BC

;

Regulatory Battles Have Been Present Throughout U.S. History

Caesars Entertainment (CZR) went public in an unusual stock offering today, and shares are already way above the offering price. In fact, in midday trading they were trading hands at $13.91 per share, 57% above the $9 offering price. But the dynamics of this odd IPO make it difficult to determine just how successful it [...]

;

T. Rowe Price Group Beats Estimates on Top and Bottom Lines

T. Rowe Price Group (Nasdaq: TROW  ) reported earnings on Jan. 27. Here are the numbers you need to know. The 10-second takeawayFor the quarter ended Dec. 31 (Q4), T. Rowe Price Group beat slightly on revenues and beat expectations on earnings per share. Compared to the prior-year quarter, revenue grew, and GAAP earnings per share [...]